Cases 11 - 20 of 48
MITSUBISHI TANABE PHARMA CORPORATION et al v. MACLEODS PHARMACEUTICALS, LTD. et al
as 1:2021cv00697
Plaintiff:
JANSSEN RESEARCH AND DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV, MITSUBISHI TANABE PHARMA CORPORATION and others
Defendant:
MACLEODS PHARMA USA, INC. and MACLEODS PHARMACEUTICALS, LTD.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2020cv01180
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv02065
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
NOVARTIS PHARMACEUTICALS CORPORATION v. MACLEODS PHARMACEUTICALS LTD. et al
as 3:2019cv19345
Defendant:
MACLEODS PHARMACEUTICALS LTD. and MACLEODS PHARMA USA, INC.
Plaintiff:
NOVARTIS PHARMACEUTICALS CORPORATION
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2019cv02021
Defendant:
Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Alembic Global Holding SA and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim International GmbH et al v. Macleods Pharamceuticals Ltd. et al
as 1:2019cv01864
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv01772
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property GMBH et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv00880
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
